Back

Δ246p53 is a new p53 isoform that responds to DNA damage and regulates tumour growth

Parkar, S. N.; Lopez-Iniesta, M. J.; Ramalho, A. C.; Kimura, K.; Zhao, J.; da Silva Rita, F.; Romao, L.; Candeias, M. M.

2023-04-08 cancer biology
10.1101/2023.04.07.536059 bioRxiv
Show abstract

p53 is with little doubt one of the most powerful genes in our genome, as it makes growth vs arrest, repair vs replacement, metabolism vs anabolism, life vs death decisions in the cell. An alteration or malfunction in p53 may lead to cancer or premature ageing. So, it is not surprising that p53 is also one of the most complex and tightly regulated genes. p53 alone encodes for at least 10 RNA variants and 12 widely accepted protein forms. Here we identify one new p53 protein isoform of around 18 kDa that we termed {Delta}246p53. {Delta}246p53 is translated from an alternative translation initiation site (TIS) in codon 246. TIS-246 is preceded by a strong Kozak sequence and appears conserved in vertebrates, from sea lamprey to humans. {Delta}246p53s origin and expression in cells were confirmed by frameshift and start codon mutations as well as siRNAs and an antisense oligo targeting TIS-246, which knocked-down {Delta}246p53 with little or no effect on full-length (FL) p53 protein levels. {Delta}246p53 was induced by DNA damage in several cancer and non-cancer cell lines and triggered senescence and impaired tumour formation/growth in colony formation assays. Lastly, we show that {Delta}246p53 inhibits Hdm2 expression and activates p21, a known senescence activator gene, through FLp53-dependent and -independent mechanisms, respectively. Our results add yet another regulated and naturally occurring factor to the list of p53 players, with specific roles in p53 activation and senescence. Further studies on {Delta}246p53s regulation and mode of action may help us better understand p53s still mystifying functions in senescence and ageing.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cell Death & Disease
126 papers in training set
Top 0.1%
18.3%
2
Cell Death & Differentiation
48 papers in training set
Top 0.1%
18.3%
3
Scientific Reports
3612 papers in training set
Top 13%
6.2%
4
Molecular Oncology
55 papers in training set
Top 0.1%
5.4%
5
Cellular and Molecular Life Sciences
96 papers in training set
Top 0.3%
3.2%
50% of probability mass above
6
Cell Death Discovery
58 papers in training set
Top 0.2%
3.2%
7
Nucleic Acids Research
1281 papers in training set
Top 6%
2.7%
8
International Journal of Molecular Sciences
494 papers in training set
Top 5%
2.6%
9
Aging
75 papers in training set
Top 0.6%
2.4%
10
Molecular and Cellular Biology
47 papers in training set
Top 0.3%
2.1%
11
eLife
5828 papers in training set
Top 44%
2.1%
12
iScience
1154 papers in training set
Top 17%
1.7%
13
Open Biology
106 papers in training set
Top 0.7%
1.7%
14
Cells
249 papers in training set
Top 4%
1.5%
15
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.5%
1.1%
16
Communications Biology
993 papers in training set
Top 22%
1.1%
17
Frontiers in Molecular Biosciences
102 papers in training set
Top 1%
1.1%
18
PLOS ONE
5266 papers in training set
Top 58%
1.0%
19
Redox Biology
70 papers in training set
Top 1%
1.0%
20
Life Science Alliance
285 papers in training set
Top 7%
0.9%
21
Oncogenesis
12 papers in training set
Top 0.4%
0.8%
22
Cancers
213 papers in training set
Top 5%
0.8%
23
Heliyon
152 papers in training set
Top 8%
0.8%
24
International Journal of Cancer
49 papers in training set
Top 1%
0.8%
25
Nature Communications
5641 papers in training set
Top 60%
0.6%
26
Neoplasia
23 papers in training set
Top 1%
0.6%
27
Biochemical and Biophysical Research Communications
84 papers in training set
Top 3%
0.6%
28
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
29 papers in training set
Top 0.8%
0.6%
29
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 6%
0.6%